Fecal Calprotectin in Cystic Fibrosis

Medical College of Wisconsin

Status: Completed

Conditions: Cystic Fibrosis

Study type: Observational

Funder types: Other

Identifiers

NCT00863694

calpro

Details and patient eligibility

About

Elevated fecal calprotectin is a biomarker for intestinal inflammation in cystic fibrosis

Enrollment: 106 patients

Sex: All

Ages: 1+ month old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients

Exclusion criteria

• Informed consent/assent not obtained